search
Back to results

Prospective Study of Altis System With the TVTO Procedure for the Management of Stress Urinary Incontinence in Women

Primary Purpose

Genuine Stress Incontinence

Status
Unknown status
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Altis tape
TVTO
Sponsored by
Aretaieio Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Genuine Stress Incontinence focused on measuring stress incontinence, female, altis, transobturator tape, minisling

Eligibility Criteria

25 Years - 80 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusin Criteria:

  • Having genuine stress urinary incontinence proven by urodynamics
  • be willing to be operated and participate in the study.

Exclusion Criteria:

  • History of previous irradiation in the lower genital tract
  • BMI more than 30kg/m2
  • previous anti-incontinence surgery, previous vaginal surgery
  • having MUCP< 30 cm H2O or Valsava leak point pressure less than than 60 cm H2O
  • Mixed urinary incontinence.

Sites / Locations

  • Aretaieio University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

group A

group B

Arm Description

Altis tape surgical placement

TVT transobturator tape placement

Outcomes

Primary Outcome Measures

the objective urinary continence rate at 12 months
Primary outcome measure will be the objective urinary continence rate at 12 months as it is assessed with cough stress test during urodynamics.

Secondary Outcome Measures

Subjective urinary continence rate at 12 months follow up
Secondary outcome measure will be the subjective continence rate as it is assessed with the use of the PGI-I questionnaire.
Preoperative and postoperative assessment of sexual function
Patients will be asked to complete preoperatively and postoperatively the female sexual function index. Minimum score 2.0 and maximum score 36.0. Higher values represent a better outcome.

Full Information

First Posted
March 23, 2018
Last Updated
April 22, 2018
Sponsor
Aretaieio Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03515109
Brief Title
Prospective Study of Altis System With the TVTO Procedure for the Management of Stress Urinary Incontinence in Women
Official Title
Prospective Randomized Trial of Altis Minisling With the TVTO Transobturator Tape Procedure for the Management of Genuine Stress Urinaty Incontinence in Women
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Unknown status
Study Start Date
November 25, 2017 (Actual)
Primary Completion Date
March 25, 2018 (Actual)
Study Completion Date
November 25, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aretaieio Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Prospective randomized comparison of minisling (altis) with the TVTO procedure for the management of women with genuine stress urinary incontinence.
Detailed Description
Prospective randomized study double blinded. Two group of patients consisting group A of 40 patients being operated with altis minisling and group B with 40 patients operated with TVTO procedure. All patients will be operated with epidural anesthesia. The patients participating in the study will meet the following requirements. a. Having genuine stress urinary incontinence proven by urodynamics, b. be willing to be operated and participate in the study. Exclusion criteria wil be the following: a.History of previous irradiation in the lower genital tract, b. BMI more than 30kg/m2, c.previous anti-incontinence surgery, previous vaginal surgery, e. having MUCP< 20 cm H2O or Valsava leak point pressure less than than 60 cm H2O. Patients will be allocated in each operation by an automatic system using a computer software. Primary outcome measure will be the objective cure rate at 6 months as it is assessed with cough stress test during urodynamics. Secondary outcome measures will be the subjective cure rate, improvement and failure rate, the incidence of complications such as obstruction, voiding difficulties, hemorrhage etc. Patients will be asked to complete preoperatively and postoperatively the ICIQ-FLUTS, patient satisfaction questionnaire and the female sexual function index.postoperatively the patients will complete the PGI-I questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Genuine Stress Incontinence
Keywords
stress incontinence, female, altis, transobturator tape, minisling

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
prospective randomised
Masking
ParticipantInvestigator
Masking Description
they will not be aware of the procedure they are going to perform or have.
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
group A
Arm Type
Active Comparator
Arm Description
Altis tape surgical placement
Arm Title
group B
Arm Type
Placebo Comparator
Arm Description
TVT transobturator tape placement
Intervention Type
Procedure
Intervention Name(s)
Altis tape
Intervention Description
placement of Altis tape through transobturator foramen bilaterally under epidural anesthesia
Intervention Type
Procedure
Intervention Name(s)
TVTO
Intervention Description
placement of TVTO tape through transobturator foarmen bilaterally under epidural anesthesia
Primary Outcome Measure Information:
Title
the objective urinary continence rate at 12 months
Description
Primary outcome measure will be the objective urinary continence rate at 12 months as it is assessed with cough stress test during urodynamics.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Subjective urinary continence rate at 12 months follow up
Description
Secondary outcome measure will be the subjective continence rate as it is assessed with the use of the PGI-I questionnaire.
Time Frame
1year
Title
Preoperative and postoperative assessment of sexual function
Description
Patients will be asked to complete preoperatively and postoperatively the female sexual function index. Minimum score 2.0 and maximum score 36.0. Higher values represent a better outcome.
Time Frame
1 year

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusin Criteria: Having genuine stress urinary incontinence proven by urodynamics be willing to be operated and participate in the study. Exclusion Criteria: History of previous irradiation in the lower genital tract BMI more than 30kg/m2 previous anti-incontinence surgery, previous vaginal surgery having MUCP< 30 cm H2O or Valsava leak point pressure less than than 60 cm H2O Mixed urinary incontinence.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
PANAGIOTIS VAKAS
Phone
2107473204
Email
P_BAKAS@YAHOO.COM
First Name & Middle Initial & Last Name or Official Title & Degree
Emmanouil papadakis, Dr
Phone
6944864531
Email
papadakisemm2@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
PANAGIOTIS VAKAS
Organizational Affiliation
aretaieio university hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aretaieio University Hospital
City
Athens
State/Province
Attiki
ZIP/Postal Code
11528
Country
Greece
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
PANAGIOTIS VAKAS
Phone
2107473204
Email
P_BAKAS@YAHOO.COM

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Prospective Study of Altis System With the TVTO Procedure for the Management of Stress Urinary Incontinence in Women

We'll reach out to this number within 24 hrs